Can Dermira Stock Keep Soaring?
The skincare specialist's experimental eczema treatment hit the mark in mid-stage testing, but what about the road ahead?
The move could be aimed at protecting investors, who helped him buy purchase X, from losing money. from BBC News https://ift.tt/upf7MHS
0 comments:
Post a Comment